Research programme: skin and mouth disorders therapy - HealOr

Drug Profile

Research programme: skin and mouth disorders therapy - HealOr

Alternative Names: HO 0202; HO-0210; HO-0408; HO-0409; HO-0709; HO/02/02; HO/02/10; HO/04/08; HO/04/09; HO/07/09

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator HealOr
  • Class
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Acne; Dry skin; Plaque psoriasis; Radiation-induced skin damage; Skin disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in Israel (Topical)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Dry-skin in Israel (Topical)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Plaque-psoriasis in Israel (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top